Stomach Cancer Trial, Recruiting NCT04665687 Sponsor: Samsung Medical Center Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT04665687
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 19 years of age or older
  • You have been diagnosed with early stomach cancer or a precancerous stomach growth (called gastric adenoma), confirmed by a tissue test
  • You have leftover tissue samples already stored from a previous biopsy or endoscopic procedure done for your treatment or diagnosis (not for research)
  • Your doctors expect you to live for at least 3 more months
  • You are willing to voluntarily agree to take part in this clinical trial

Who may not be able to join:

  • There is not enough stored tissue available from you to provide usable samples for the study
  • The researchers decide, for any reason, that it would not be appropriate for you to take part in this study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hyuk Lee, MD, PhD, Samsung Medical Center

Phone: 82234106853

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
17 December 2020
Est. completion
31 December 2029

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Identify biomarkers for differential diagnosis between early gastric cancer and precancerous adenoma.; Indentify prognostic biomarkers for predicting recurrence of early gastric cancer and precancerous adenoma lesion.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov